[1] |
Landry GJ. Current medical and surgical management of Raynaud’s syndrome. J Vasc Surg 2013; 57(6):1710-6. doi: 10.1016/j.jvs.2013.03.012.
doi: 10.1016/j.jvs.2013.03.012
|
[2] |
Gayraud M. Raynaud’s phenomenon. Joint Bone Spine 2007; 74(1):e1-8. doi: 10.1016/j.jbspin.2006.07.002.
doi: 10.1016/j.jbspin.2006.07.002
|
[3] |
Chikura B, Moore TL, Manning JB, et al. Sparing of the thumb in Raynaud’s phenomenon. Rheumatology (Oxford) 2008; 47(2):219-21. doi: 10.1093/rheumatology/kem353.
doi: 10.1093/rheumatology/kem353
pmid: 18208825
|
[4] |
Wigley FM, Flavahan NA. Raynaud’s Phenomenon. N Engl J Med 2016; 375(6):556-65. doi: 10.1056/NEJMra1507638.
doi: 10.1056/NEJMra1507638
|
[5] |
Pauling JD, Hughes M, Pope JE. Raynaud’s phenomenon—an update on diagnosis, classification and management. Clin Rheumatol 2019; 38(12):3317-30. doi: 10.1007/s10067-019-04745-5.
doi: 10.1007/s10067-019-04745-5
pmid: 31420815
|
[6] |
Belch J, Carlizza A, Carpentier PH, et al. ESVM guidelines— the diagnosis and management of Raynaud’s phenomenon. Vasa 2017; 46(6):413-23. doi: 10.1024/0301-1526/a000661.
doi: 10.1024/0301-1526/a000661
pmid: 28895508
|
[7] |
Juche A, Siegert E, Mueller-Ladner U, et al. Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany. Z Rheumatol 2020; 79(10):1057-66. doi: 10.1007/s00393-019-00743-9.
doi: 10.1007/s00393-019-00743-9
|
[8] |
Hughes M, Ong VH, Anderson ME, et al. Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis. Rheumatology (Oxford) 2015; 54(11):2015-24. doi: 10.1093/rheumatology/kev201.
doi: 10.1093/rheumatology/kev201
pmid: 26116156
|
[9] |
Rinkinen J, Halvorson EG. Topical vasodilators in microsurgery: what is the evidence? J Reconstr Microsurg 2017; 33(1):1-7. doi: 10.1055/s-0036-1592191.
doi: 10.1055/s-0036-1592191
pmid: 27636540
|
[10] |
Ma Q, Liu D, Gong R, et al. Mechanically induced vasospasm-evaluation of spasmolytic efficacy of 10 pharmaceutical agents using laser speckle contrast imaging. Lasers Surg Med 2021; 53(5):684-94. doi: 10.1002/lsm.23347.
doi: 10.1002/lsm.23347
pmid: 33259664
|
[11] |
Vargas CR, Iorio ML, Lee BT. A systematic review of topical vasodilators for the treatment of intraoperative vasospasm in reconstructive microsurgery. Plast Reconstr Surg 2015; 136(2):411-22. doi: 10.1097/PRS.0000000000001431.
doi: 10.1097/PRS.0000000000001431
pmid: 25909299
|
[12] |
Andrigueti FV, Ebbing PCC, Arismendi MI, et al. Evaluation of the effect of sildenafil on the microvascular blood flow in patients with systemic sclerosis: a randomised, double-blind, placebo-controlled study. Clin Exp Rheumatol 2017; 106(4):151-8.
|
[13] |
Hachulla E, Hatron PY, Carpentier P, et al. Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study. Ann Rheum Dis 2016; 75(6):1009-15. doi: 10.1136/annrheumdis-2014-207001.
doi: 10.1136/annrheumdis-2014-207001
pmid: 25995322
|
[14] |
Sahin OF, Tarikci Kilic E, Aksoy Y, et al. The importance of perfusion index monitoring in evaluating the efficacy of stellate ganglion blockage treatment in Raynaud’s disease. Libyan J Med 2018; 13(1): 1422666. doi: 10.1080/19932820.2017.1422666.
doi: 10.1080/19932820.2017.1422666
|
[15] |
Vegas DH, Fabiani MA, Gonzalez-Urquijo M, et al. Novel combined approach for digital necrosis secondary to Raynaud’s phenomenon. Vasc Endovascular Surg 2021; 55(7):766-71. doi: 10.1177/15385744211005663.
doi: 10.1177/15385744211005663
|
[16] |
Isei T, Abe M, Nakanishi T, et al. The wound/burn guidelines-3: guidelines for the diagnosis and treatment for diabetic ulcer/gangrene. J Dermatol 2016; 43(6):591-619. doi: 10.1111/1346-8138.13285.
doi: 10.1111/1346-8138.13285
|
[17] |
Thom SR. Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg 2011; 127(Suppl 1):131S-41S. doi: 10.1097/PRS.0b013e3181fbe2bf.
doi: 10.1097/PRS.0b013e3181fbe2bf
|
[18] |
Howard MA, Asmis R, Evans KK, et al. Oxygen and wound care: a review of current therapeutic modalities and future direction. Wound Repair Regen 2013; 21(4):503-11. doi: 10.1111/wrr.12069.
doi: 10.1111/wrr.12069
pmid: 23756299
|
[19] |
Sato T, Arai K, Ichioka S. Hyperbaric oxygen therapy for digital ulcers due to Raynaud’s disease. Case Reports Plast Surg Hand Surg 2018; 5(1):72-4. doi: 10.1080/23320885.2018.1525684.
doi: 10.1080/23320885.2018.1525684
|
[20] |
Herrick A, Muir L. Raynaud’s phenomenon (secondary). BMJ Clin Evid 2014; 2014:1125.
|